Satellite Banner
Technology Networks Header
Monday, September 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Data Using EKF PointMan™ Technology
Tuesday, July 22, 2014
New data suggest the possibility of a simple blood test for cancers.

ChIP Sequencing Kit for Next Generation Sequencing
Tuesday, July 22, 2014
Company extends the benefits of their Chromatrap® solid state ChIP technology.

ACD’s RNAscope® In Situ Hybridization Technology Gains Significant Traction
Wednesday, July 16, 2014
Highly sensitive and easy-to-use technology validated in over 100 papers in three years.

QIAGEN Launch of 14 New Cancer Gene Panels
Wednesday, July 16, 2014
QIAGEN introduces 14 new panels for targeted enrichment of up to 570 clinically-relevant genes, expands largest portfolio of panels for assessing cancer genes.

SciGene Introduces High Capacity Oven
Tuesday, July 15, 2014
CytoBrite Slide Oven for performing extended FISH probe hybridizations.

PerkinElmer Launches LabChip® GX and GXII Touch™ Systems
Thursday, July 10, 2014
New automated platform provides life sciences researchers with precise nucleic acid quantification and protein characterization.

ChromaTrap™ Helps Advance Research into Women`s Reproductive Health
Wednesday, July 09, 2014
Latest research developments in women’s reproductive health using molecular biology tools.

OGT Launches High-Resolution, High-throughput PGS Array
Wednesday, July 09, 2014
Confident genome-wide aneuploidy detection in 14 samples on a single array.

Bioo Scientific Launches NEXTflex Cell Free DNA-Seq Kit
Friday, July 04, 2014
Optimized for ctDNA and cfDNA library preparation.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 2503
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv